A Post-COVID-19 World
What will our industry and economy look like in the post-COVID-19 era?First of all, we would never recommend paying too much attention to anyone who knows precisely what the answer…
Menu
Pharma Competitive Intelligence, Then and Now
Pharmaceutical and biotech competitive intelligence is increasingly important and challenging these days. Lacerta Bio discusses a recent case study in which a client learned this the hard way.
When does due diligence start?
In our view, there are two basic types of biotech business development-related due diligence. The first is external , where the team gathers and analyzes data about a target company…